Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Lars L. Thomsen"'
Autor:
Heinz Zoller, Myles Wolf, Irina Blumenstein, Christian Primas, Stefan Lindgren, Lars L Thomsen, Walter Reinisch, Tariq Iqbal
Publikováno v:
Gut. 72:644-653
ObjectiveIntravenous iron—a common treatment for anaemia and iron deficiency due to inflammatory bowel disease (IBD)—can cause hypophosphataemia. This trial compared the incidence of hypophosphataemia after treatment with ferric carboxymaltose (F
Autor:
Giorgos Leloudas, Mattia Bulla, Aleksandar Cikota, Lixin Dai, Lars L. Thomsen, Justyn R. Maund, Panos Charalampopoulos, Nathaniel Roth, Iair Arcavi, Katie Auchettl, Daniele B. Malesani, Matt Nicholl, Enrico Ramirez-Ruiz
Publikováno v:
Nature Astronomy, 6, pp. 1193-1202
Nature Astronomy, 6, 1193-1202
Nature Astronomy, 6, 1193-1202
A star crossing the tidal radius of a supermassive black hole will be spectacularly ripped apart with an accompanying burst of radiation. A few tens of such tidal disruption events (TDEs) have now been identified in the optical wavelengths, but the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dc47aac0a6ecc3ea342e596108834fe
http://arxiv.org/abs/2207.06855
http://arxiv.org/abs/2207.06855
Publikováno v:
Nephrology Dialysis Transplantation
Background The optimal intravenous (IV) iron would allow safe correction of iron deficiency at a single infusion over a short time. The FERWON-NEPHRO trial evaluated the safety and efficacy of iron isomaltoside 1000/ferric derisomaltose (IIM) in pati
Publikováno v:
Obesity surgery. 32(3)
Purpose Iron deficiency is common following bariatric surgery, and treatment with intravenous iron is often required. This post hoc analysis of data from two randomized, open-label, multicenter trials evaluated the efficacy and safety of ferric deris
Autor:
Lars L. Thomsen, Sunil Bhandari, John A. Glaspy, Philip A. Kalra, Myles Wolf, Michael Auerbach
Publikováno v:
American Journal of Hematology
Autor:
Eloy Roman, Maureen Achebe, Michael Auerbach, Richard J. Derman, Lars L. Thomsen, Manuel R. Modiano
Publikováno v:
American Journal of Hematology
Iron deficiency anemia (IDA) is common in many chronic diseases, and intravenous (IV) iron offers a rapid and efficient iron correction. This trial compared the efficacy and safety of iron isomaltoside (also known as ferric derisomaltose) and iron su
Autor:
Eloy Roman, Lars L. Thomsen, Maureen Achebe, Michael Auerbach, Gioi N. Smith‐Nguyen, Richard J. Derman
Publikováno v:
American Journal of Hematology
Autor:
Sunil Bhandari, Lars L. Thomsen
Publikováno v:
Nephrology Dialysis Transplantation. 34
Autor:
Lars L. Thomsen, Sunil Bhandari
Publikováno v:
Nephrology Dialysis Transplantation. 34
Autor:
Lars L. Thomsen, Maureen Achebe, Michael Auerbach, John A. Glaspy, Richard J. Derman, David H. Henry
Publikováno v:
American Journal of Hematology
Iron deficiency anemia (IDA) is prevalent, and intravenous iron, especially if given in a single dose, may result in better adherence compared with oral iron. The present trial (FERWON‐IDA) is part of the FERWON program with iron isomaltoside 1000/